PortfoliosLab logo
MOH vs. CPRX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MOH and CPRX is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

MOH vs. CPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Molina Healthcare, Inc. (MOH) and Catalyst Pharmaceuticals, Inc. (CPRX). The values are adjusted to include any dividend payments, if applicable.

200.00%400.00%600.00%800.00%1,000.00%1,200.00%1,400.00%NovemberDecember2025FebruaryMarchApril
1,250.30%
280.16%
MOH
CPRX

Key characteristics

Sharpe Ratio

MOH:

-0.30

CPRX:

1.29

Sortino Ratio

MOH:

-0.15

CPRX:

2.13

Omega Ratio

MOH:

0.98

CPRX:

1.24

Calmar Ratio

MOH:

-0.36

CPRX:

1.77

Martin Ratio

MOH:

-0.89

CPRX:

7.50

Ulcer Index

MOH:

14.89%

CPRX:

7.14%

Daily Std Dev

MOH:

44.74%

CPRX:

41.48%

Max Drawdown

MOH:

-68.37%

CPRX:

-94.25%

Current Drawdown

MOH:

-25.20%

CPRX:

-9.91%

Fundamentals

Market Cap

MOH:

$18.16B

CPRX:

$2.82B

EPS

MOH:

$20.43

CPRX:

$1.34

PE Ratio

MOH:

16.25

CPRX:

17.25

PEG Ratio

MOH:

-0.62

CPRX:

0.00

PS Ratio

MOH:

0.46

CPRX:

5.73

PB Ratio

MOH:

4.04

CPRX:

3.79

Total Revenue (TTM)

MOH:

$30.70B

CPRX:

$393.23M

Gross Profit (TTM)

MOH:

$3.50B

CPRX:

$327.56M

EBITDA (TTM)

MOH:

$1.42B

CPRX:

$177.46M

Returns By Period

In the year-to-date period, MOH achieves a 7.82% return, which is significantly lower than CPRX's 11.12% return. Over the past 10 years, MOH has underperformed CPRX with an annualized return of 17.63%, while CPRX has yielded a comparatively higher 21.40% annualized return.


MOH

YTD

7.82%

1M

1.06%

6M

-3.02%

1Y

-14.59%

5Y*

13.32%

10Y*

17.63%

CPRX

YTD

11.12%

1M

-9.84%

6M

8.31%

1Y

53.37%

5Y*

35.94%

10Y*

21.40%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MOH vs. CPRX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MOH
The Risk-Adjusted Performance Rank of MOH is 3333
Overall Rank
The Sharpe Ratio Rank of MOH is 3636
Sharpe Ratio Rank
The Sortino Ratio Rank of MOH is 3333
Sortino Ratio Rank
The Omega Ratio Rank of MOH is 3434
Omega Ratio Rank
The Calmar Ratio Rank of MOH is 2929
Calmar Ratio Rank
The Martin Ratio Rank of MOH is 3232
Martin Ratio Rank

CPRX
The Risk-Adjusted Performance Rank of CPRX is 8989
Overall Rank
The Sharpe Ratio Rank of CPRX is 8989
Sharpe Ratio Rank
The Sortino Ratio Rank of CPRX is 8888
Sortino Ratio Rank
The Omega Ratio Rank of CPRX is 8383
Omega Ratio Rank
The Calmar Ratio Rank of CPRX is 9292
Calmar Ratio Rank
The Martin Ratio Rank of CPRX is 9292
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MOH vs. CPRX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Molina Healthcare, Inc. (MOH) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for MOH, currently valued at -0.30, compared to the broader market-2.00-1.000.001.002.003.00
MOH: -0.30
CPRX: 1.29
The chart of Sortino ratio for MOH, currently valued at -0.15, compared to the broader market-6.00-4.00-2.000.002.004.00
MOH: -0.15
CPRX: 2.13
The chart of Omega ratio for MOH, currently valued at 0.98, compared to the broader market0.501.001.502.00
MOH: 0.98
CPRX: 1.24
The chart of Calmar ratio for MOH, currently valued at -0.36, compared to the broader market0.001.002.003.004.005.00
MOH: -0.36
CPRX: 1.77
The chart of Martin ratio for MOH, currently valued at -0.89, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
MOH: -0.89
CPRX: 7.50

The current MOH Sharpe Ratio is -0.30, which is lower than the CPRX Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of MOH and CPRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50NovemberDecember2025FebruaryMarchApril
-0.30
1.29
MOH
CPRX

Dividends

MOH vs. CPRX - Dividend Comparison

Neither MOH nor CPRX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MOH vs. CPRX - Drawdown Comparison

The maximum MOH drawdown since its inception was -68.37%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for MOH and CPRX. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-25.20%
-9.91%
MOH
CPRX

Volatility

MOH vs. CPRX - Volatility Comparison

Molina Healthcare, Inc. (MOH) has a higher volatility of 16.07% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 14.57%. This indicates that MOH's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
16.07%
14.57%
MOH
CPRX

Financials

MOH vs. CPRX - Financials Comparison

This section allows you to compare key financial metrics between Molina Healthcare, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items